Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States).

Costello LC, Franklin RB, Feng P, Tan M, Bagasra O.

Cancer Causes Control. 2005 Oct;16(8):901-15. Review.

PMID:
16132800
2.

Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve.

Costello LC, Feng P, Milon B, Tan M, Franklin RB.

Prostate Cancer Prostatic Dis. 2004;7(2):111-7. Review.

3.

Zinc supplement use and risk of prostate cancer.

Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL.

J Natl Cancer Inst. 2003 Jul 2;95(13):1004-7.

PMID:
12837837
4.
5.
7.

Prostate cancer and inositol hexaphosphate: efficacy and mechanisms.

Singh RP, Agarwal R.

Anticancer Res. 2005 Jul-Aug;25(4):2891-903. Review.

9.

Testosterone and prostate cancer: revisiting old paradigms.

Isbarn H, Pinthus JH, Marks LS, Montorsi F, Morales A, Morgentaler A, Schulman C.

Eur Urol. 2009 Jul;56(1):48-56. doi: 10.1016/j.eururo.2009.03.088. Epub 2009 Apr 8. Review.

PMID:
19375844
10.

Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence.

Van Patten CL, de Boer JG, Tomlinson Guns ES.

J Urol. 2008 Dec;180(6):2314-21; discussion 2721-2. doi: 10.1016/j.juro.2008.08.078. Epub 2008 Oct 18. Review.

PMID:
18930254
11.

Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands.

Johnson LA, Kanak MA, Kajdacsy-Balla A, Pestaner JP, Bagasra O.

Methods. 2010 Dec;52(4):316-21. doi: 10.1016/j.ymeth.2010.08.004. Epub 2010 Aug 10.

PMID:
20705137
12.

The role of testosterone in the pathogenesis of prostate cancer.

Imamoto T, Suzuki H, Yano M, Kawamura K, Kamiya N, Araki K, Komiya A, Nihei N, Naya Y, Ichikawa T.

Int J Urol. 2008 Jun;15(6):472-80. doi: 10.1111/j.1442-2042.2008.02074.x. Epub 2008 Apr 22. Review.

13.

Soy isoflavone genistein in prevention and treatment of prostate cancer.

Perabo FG, Von Löw EC, Ellinger J, von Rücker A, Müller SC, Bastian PJ.

Prostate Cancer Prostatic Dis. 2008;11(1):6-12. Epub 2007 Oct 9. Review.

PMID:
17923857
14.
15.

Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.

Carruba G.

J Cell Biochem. 2007 Nov 1;102(4):899-911. Review.

PMID:
17786930
16.

Role of diet in prostate cancer development and progression.

Chan JM, Gann PH, Giovannucci EL.

J Clin Oncol. 2005 Nov 10;23(32):8152-60. Review.

PMID:
16278466
17.

Impact of diet on prostate cancer: a review.

Sonn GA, Aronson W, Litwin MS.

Prostate Cancer Prostatic Dis. 2005;8(4):304-10. Review.

PMID:
16130015
18.

The use of PSA as biomarker in nutritional intervention studies of prostate cancer.

van Weerden WM, Schröder FH.

Chem Biol Interact. 2008 Jan 30;171(2):204-11. doi: 10.1016/j.cbi.2007.11.006. Epub 2007 Nov 22. Review.

PMID:
18177847
19.

Prostate cancer prevention: past, present, and future.

Fleshner N, Zlotta AR.

Cancer. 2007 Nov 1;110(9):1889-99. Review.

20.

Role of zinc and zinc transporters in the molecular pathogenesis of diabetes mellitus.

Quraishi I, Collins S, Pestaner JP, Harris T, Bagasra O.

Med Hypotheses. 2005;65(5):887-92.

PMID:
16043303

Supplemental Content

Support Center